Ki Duk Park

4.2k total citations
116 papers, 2.7k citations indexed

About

Ki Duk Park is a scholar working on Molecular Biology, Cellular and Molecular Neuroscience and Organic Chemistry. According to data from OpenAlex, Ki Duk Park has authored 116 papers receiving a total of 2.7k indexed citations (citations by other indexed papers that have themselves been cited), including 49 papers in Molecular Biology, 40 papers in Cellular and Molecular Neuroscience and 19 papers in Organic Chemistry. Recurrent topics in Ki Duk Park's work include Neuroscience and Neuropharmacology Research (21 papers), Genomics, phytochemicals, and oxidative stress (14 papers) and Parkinson's Disease Mechanisms and Treatments (13 papers). Ki Duk Park is often cited by papers focused on Neuroscience and Neuropharmacology Research (21 papers), Genomics, phytochemicals, and oxidative stress (14 papers) and Parkinson's Disease Mechanisms and Treatments (13 papers). Ki Duk Park collaborates with scholars based in South Korea, United States and Egypt. Ki Duk Park's co-authors include Jong‐Hyun Park, Rajesh Khanna, Seul Ki Yeon, Ae Nim Pae, Bo Ko Jang, Sung Jin Cho, Dong Jin Kim, Jin‐Sung Choi, Sung Uk Kim and Sung‐Han Kim and has published in prestigious journals such as Journal of the American Chemical Society, Journal of Biological Chemistry and ACS Nano.

In The Last Decade

Ki Duk Park

113 papers receiving 2.6k citations

Peers

Countries citing papers authored by Ki Duk Park

Since Specialization

Citations

This map shows the geographic impact of Ki Duk Park's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ki Duk Park with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ki Duk Park more than expected).

Fields of papers citing papers by Ki Duk Park

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ki Duk Park. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ki Duk Park. The network helps show where Ki Duk Park may publish in the future.

Co-authorship network of co-authors of Ki Duk Park

This figure shows the co-authorship network connecting the top 25 collaborators of Ki Duk Park. A scholar is included among the top collaborators of Ki Duk Park based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ki Duk Park. Ki Duk Park is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	KDS2010, a reversible MAO‐B inhibitor, extends the lifetime of neural probes by preventing glial scar formation 2024 ·Glia ·Uikyu Chae, Heejung Chun, Jiwoon Lim, Hyogeun Shin, (unknown), Ji Won Choi, Ki Duk Park, C. Justin Lee, Il‐Joo Cho	3
2	Discovery and Optimization of a Series of Vinyl Sulfoximine-Based Analogues as Potent Nrf2 Activators for the Treatment of Multiple Sclerosis 2024 ·Journal of Medicinal Chemistry ·(unknown), Jaehwan Kim, (unknown), (unknown), Hyeon Jeong Kim, (unknown), (unknown), (unknown), (unknown), Sangin Park, Hyemin Kim, (unknown), Jaeick Lee, Yong‐Sun Bahn, (unknown), Jong‐Hyun Park, Ki Duk Park	6
3	A Retro-Aldol Reaction Prompted the Evolvability of a Phosphotransferase System for the Utilization of a Rare Sugar 2023 ·Microbiology Spectrum ·(unknown), (unknown), (unknown), (unknown), (unknown), Ki Duk Park, (unknown), Dong‐Woo Lee	1
4	Synthesis and Biological Evaluation of O6-Aminoalkyl-Hispidol Analogs as Multifunctional Monoamine Oxidase-B Inhibitors towards Management of Neurodegenerative Diseases 2023 ·Antioxidants ·Ahmed H.E. Hassan, (unknown), (unknown), (unknown), (unknown), (unknown), Yeon Ju Kim, (unknown), Min Sung Gee, Danbi Lee, Jong‐Hyun Park, Jong Kil Lee, Jong Hoon Ryu, Ki Duk Park, Yong Sup Lee	6
5	Hypothalamic GABRA5-positive neurons control obesity via astrocytic GABA 2023 ·Nature Metabolism ·(unknown), (unknown), Wuhyun Koh, Mingu Gordon Park, Hyun‐Jun Jang, Yong Ryoul Yang, Mridula Bhalla, (unknown), Jiwoon Lim, Woojin Won, Jea Kwon, (unknown), (unknown), (unknown), Heeyoung An, Seung Eun Lee, Ki Duk Park, Pann‐Ghill Suh, Jong‐Woo Sohn, C. Justin Lee	21
6	Optimization and evaluation of pyridinyl vinyl sulfones as Nrf2 activator for the antioxidant and anti-inflammatory effects 2023 ·European Journal of Medicinal Chemistry ·(unknown), (unknown), Hyeon Jeong Kim, (unknown), (unknown), (unknown), (unknown), Jaehwan Kim, Ji Won Choi, Jong‐Hyun Park, Ki Duk Park	9
7	Development of Dibenzothiazepine Derivatives as Multifunctional Compounds for Neuropathic Pain 2022 ·Pharmaceuticals ·Kwan‐Young Jung, Yeo Ok Kim, (unknown), Hyung Gon Lee, (unknown), (unknown), (unknown), Siwon Kim, Seon Hee Seo, Jong‐Hyun Park, Ki Duk Park, Woong Mo Kim, Myung Ha Yoon, Yong‐Chul Kim	1
8	Inhibiting peripheral and central MAO-B ameliorates joint inflammation and cognitive impairment in rheumatoid arthritis 2022 ·Experimental & Molecular Medicine ·Woojin Won, Hyun‐Ji Choi, Jiyoung Yoo, (unknown), Tai Young Kim, Yeon Ha Ju, Ki Duk Park, Hyunbeom Lee, Youn‐Sang Jung, C. Justin Lee	20
9	Discovery of Novel Sphingosine-1-Phosphate-1 Receptor Agonists for the Treatment of Multiple Sclerosis 2022 ·Journal of Medicinal Chemistry ·(unknown), Seul Ki Yeon, (unknown), Hyeon Jeong Kim, Siwon Kim, (unknown), Ji Won Choi, (unknown), (unknown), (unknown), Seon Hee Seo, Jaeick Lee, Jun Woo Kim, Ha-Yeon Lee, Hayoung Hwang, Yong‐Sun Bahn, Eunji Cheong, Jong‐Hyun Park, Ki Duk Park	10
10	Synthesis and Evaluation of Serinolamide Derivatives as Sphingosine-1-Phosphate-1 (S1P1) Receptor Agonists 2022 ·Molecules ·(unknown), (unknown), Jaehwan Kim, (unknown), (unknown), Hyeon Jeong Kim, Siwon Kim, (unknown), (unknown), Ji Won Choi, Jong‐Hyun Park, Ki Duk Park	2
11	Optimization and Evaluation of Novel Antifungal Agents for the Treatment of Fungal Infection 2021 ·Journal of Medicinal Chemistry ·Ji‐Won Choi, Kyung-Tae ‍Lee, Siwon Kim, (unknown), Ji Eun Kim, Kyung Jin Seo, (unknown), Seul Ki Yeon, Bo Ko Jang, (unknown), Hyeon Jeong Kim, Jong‐Hyun Park, (unknown), Dong‐Gi Lee, Eunji Cheong, (unknown), Yong‐Sun Bahn, Ki Duk Park	14
12	Melatonin Analogues Potently Inhibit MAO-B and Protect PC12 Cells against Oxidative Stress 2021 ·Antioxidants ·Ahmed Elkamhawy, (unknown), Noha Gouda, (unknown), Hossam Nada, Eun Joo Roh, Ki Duk Park, (unknown), Kyeong Lee	26
13	PyrPeg, a Blood–Brain-Barrier-Penetrating Two-Photon Imaging Probe, Selectively Detects Neuritic Plaques, Not Tau Aggregates 2020 ·ACS Chemical Neuroscience ·(unknown), Yeon Ha Ju, (unknown), Seung Jae Hyeon, Changdev G. Gadhe, Jong‐Hyun Park, (unknown), Seungyeop Baek, Young Soo Kim, Ki Duk Park, Ae Nim Pae, Hoon Ryu, C. Justin Lee, Bong Rae Cho	13
14	Targeting the CaVα–CaVβ interaction yields an antagonist of the N-type CaV2.2 channel with broad antinociceptive efficacy 2019 ·Pain ·Rajesh Khanna, Jie Yu, Xiaofang Yang, Aubin Moutal, Aude Chefdeville, Vijay Gokhale, (unknown), Lindsey A. Chew, Shreya S. Bellampalli, Shizhen Luo, Liberty François‐Moutal, (unknown), Taehwan Ha, Samantha Perez‐Miller, Ki Duk Park, Amol Patwardhan, John M. Streicher, Henry M. Colecraft, May Khanna	35
15	Antioxidant, Anti-inflammatory, and Neuroprotective Effects of Novel Vinyl Sulfonate Compounds as Nrf2 Activator 2019 ·ACS Medicinal Chemistry Letters ·Jin‐Sung Choi, Su Jeong Shin, Ji Eun Kim, Jong‐Hyun Park, Hyeon Jeong Kim, (unknown), Ae Nim Pae, Yong‐Sun Bahn, Ki Duk Park	30
16	A novel chalcone derivative as Nrf2 activator attenuates learning and memory impairment in a scopolamine-induced mouse model 2019 ·European Journal of Medicinal Chemistry ·Hyeon Jeong Kim, Bo Ko Jang, Jong‐Hyun Park, Jin‐Sung Choi, (unknown), (unknown), Ae Nim Pae, Yong Sup Lee, Eunji Cheong, Ki Duk Park	33
17	Optimization of Vinyl Sulfone Derivatives as Potent Nuclear Factor Erythroid 2-Related Factor 2 (Nrf2) Activators for Parkinson’s Disease Therapy 2018 ·Journal of Medicinal Chemistry ·Ji Won Choi, Siwon Kim, Jong‐Hyun Park, Hyeon Jeong Kim, Su Jeong Shin, Jin Woo Kim, (unknown), Chang-Ho Lee, Sang Moon Han, Jaeick Lee, Ae Nim Pae, Gyoonhee Han, Ki Duk Park	60
18	CRISPR/Cas9 editing of Nf1 gene identifies CRMP2 as a therapeutic target in neurofibromatosis type 1-related pain that is reversed by (S)-Lacosamide 2017 ·Pain ·Aubin Moutal, Xiaofang Yang, Wennan Li, (unknown), Shizhen Luo, Song Cai, Liberty François‐Moutal, Lindsey A. Chew, Seul Ki Yeon, Shreya S. Bellampalli, Chaoling Qu, Jennifer Y. Xie, Mohab Ibrahim, May Khanna, Ki Duk Park, Frank Porreca, Rajesh Khanna	63
19	Investigation of possible horizontal gene transfer from the leaf tissue of transgenic potato to soil bacteria 2005 ·Journal of Microbiology and Biotechnology ·Young Tae Kim, Sung Eun Kim, Ki Duk Park, Tae Hoon Kang, (unknown), Sang‐Han Lee, Jae Sun Moon, Sung Uk Kim	3
20	Identification of Streptomyces sp. Producing Antibiotics Against Phytopathogenic Fungi, and Its Structure 2004 ·Journal of Microbiology and Biotechnology ·Do Hyeon Jeong, Ki Duk Park, Sung‐Han Kim, Kyung Rae Kim, Sung Won Choi, Ji Tae Kim, (unknown), Jung Han Kim	10

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact